Brain volume loss due to Donanemab Hole Ousia 3 years ago Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Estimating the true value: Aducanumab and Donanemab for Early Alzheimer DiseaseDateJuly 20, 2023In relation toAlzheimer's diseaseDonanemab: bleeding and seizuresDateJuly 20, 2023In relation toAlzheimer's diseaseDonanemab [TRAILBLAZER]DateJuly 19, 2023In relation toAlzheimer's disease
